Insmed
INSM
#963
Rank
A$36.56 B
Marketcap
A$166.67
Share price
0.58%
Change (1 day)
-43.57%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -A$0.77 Billion

According to Insmed's latest financial reports the company's current earnings are A$1.51 Billion. In 2025 the company made an earning of -A$1.73 Billion a decrease over its 2024 earnings that were of -A$1.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.77 Billion-55.53%
2025 -A$1.73 Billion43.91%
2024 -A$1.21 Billion23.71%
2023 -A$0.98 Billion45.77%
2022 -A$0.67 Billion15.83%
2021 -A$0.58 Billion50.19%
2020 -A$0.39 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.44 Billion59.35%
2017 -A$0.28 Billion8.52%
2016 -A$0.26 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$79.49 Million35.14%
2012 -A$58.83 Million-31.92%
2011 -A$86.41 Million854.92%
2010 -A$9.05 Million-105.22%
2009 A$0.17 B-905.06%
2008 -A$21.52 Million-27.31%
2007 -A$29.61 Million-62.41%
2006 -A$78.76 Million98.19%
2005 -A$39.74 Million0.03%
2004 -A$39.73 Million159.07%
2003 -A$15.34 Million-69.31%
2002 -A$49.96 Million
2000 -A$45.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$18.31 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-A$2.84 Billion 274.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.30 B-1,065.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.19 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.67 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$74.82 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA